United Statescitigroup.com/global-markets
Citigroup Global Markets Inc. (Citi) is the U.S. broker-dealer and investment banking subsidiary of Citigroup, headquartered in New York. It provides mergers and acquisitions advisory, equity and debt underwriting, corporate finance, and markets execution, alongside sales and trading in fixed income and equities and related derivatives. The firm also offers prime brokerage and clearing services. Citigroup Global Markets Inc. is registered with the U.S. Securities and Exchange Commission and is a member of FINRA and SIPC.
Within the chemical industry, Citi advises producers and materials companies on strategic transactions, divestitures, and capital raising; structures financing across public and private markets; and supports risk management for interest rates, foreign exchange, credit, and commodity exposures. The firm’s sector teams and research provide coverage of petrochemicals, polymers, industrial gases, and related value chains, informing investors and corporates on market trends and valuation dynamics.
Also known as Citigroup.
Four global coordinators appointed; IPO readiness targeted by mid‑2027; ~80% of the business moved into separate legal entities on a new ERP; Capital Markets Day set for 24 Nov 2026.
First delivery of electro‑SAF made from waste CO₂ and renewable electricity allocated to a commercial passenger flight; fuel was blended and tested to meet ASTM JetA.
Adds BPL-003 (mebufotenin benzoate intranasal) and VLS-01 (DMT buccal); upfront $6.75/share plus up to $2.50/share CVR tied to development, regulatory and DEA-rescheduling milestones.
All-stock merger creates an integrated North American chemicals platform with vertical chlorine/caustic integration, ~$12.5B pro forma revenue and $400M+ identified synergies.
Includes two late-stage ROS1 and ALK NSCLC inhibitors under FDA review for 2026 decisions, plus a HER2 candidate; expected to be accretive to profit from 2027 and funded by debt and cash.
Definitive deal to form 50/50 graphic paper JV combining two European businesses; €600m debt + €100m RCF secured; combined EV €1,420m; ~€100m annual synergies; regulatory approvals pending
Sale of select European olefins and polyolefins sites in Berre, Münchsmünster, Carrington and Tarragona closes; APS stays in Tarragona. Divested unit renamed Velogy to sharpen portfolio and capital
Fluor's CEO, CFO, and VP of Investor Relations will host one-on-one meetings at Citi's and Barclays' conferences in February 2026.
